Total Payments
$5,765
2024 Payments
$1,795
Companies
43
Transactions
368
Medicare Patients
2,711
Medicare Billing
$265,782
Payment Breakdown by Category
Food & Beverage$5,765 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,765 | 368 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,255 | 80 | $0 (2024) |
| Lilly USA, LLC | $848.14 | 63 | $0 (2024) |
| Novo Nordisk Inc | $595.69 | 38 | $0 (2024) |
| PFIZER INC. | $569.66 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $380.22 | 25 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $349.95 | 21 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $137.33 | 7 | $0 (2024) |
| Eisai Inc. | $135.75 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $118.88 | 6 | $0 (2024) |
| Lundbeck LLC | $117.26 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,795 | 103 | ABBVIE INC. ($614.29) |
| 2023 | $1,807 | 117 | AbbVie Inc. ($410.99) |
| 2022 | $790.11 | 49 | Lilly USA, LLC ($204.76) |
| 2021 | $543.26 | 38 | Lilly USA, LLC ($159.68) |
| 2020 | $259.80 | 19 | Lilly USA, LLC ($126.02) |
| 2019 | $241.38 | 16 | GlaxoSmithKline, LLC. ($47.11) |
| 2018 | $201.96 | 16 | GlaxoSmithKline, LLC. ($43.94) |
| 2017 | $126.81 | 10 | Shire North American Group Inc ($37.96) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Central Nervous System | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.47 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Rare Disease | ||||||
| 11/20/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: EPILEPSY | ||||||
| 11/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.58 | General |
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Neuropsychiatry | ||||||
| 10/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Neurology | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 540 | 981 | $163,704 | $67,700 |
| 2022 | 16 | 751 | 1,202 | $187,546 | $76,765 |
| 2021 | 15 | 782 | 1,238 | $180,525 | $76,435 |
| 2020 | 15 | 638 | 751 | $113,548 | $44,882 |
Total Patients
2,711
Total Services
4,172
Medicare Billing
$265,782
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 427 | $90,171 | $34,946 | 38.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 99 | 99 | $22,039 | $11,984 | 54.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 28 | 111 | $11,322 | $5,194 | 45.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $8,606 | $3,649 | 42.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 47 | 49 | $9,065 | $3,511 | 38.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 52 | $5,980 | $1,837 | 30.7% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 13 | 13 | $4,485 | $1,670 | 37.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 55 | $1,925 | $1,591 | 82.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 28 | $4,128 | $1,561 | 37.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 33 | 65 | $2,860 | $599.76 | 21.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 13 | 13 | $1,300 | $501.41 | 38.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $643.00 | $376.09 | 58.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 15 | $900.00 | $219.05 | 24.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 28 | $280.00 | $61.60 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 190 | 484 | $101,156 | $38,115 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 107 | 107 | $23,647 | $13,227 | 55.9% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 32 | 74 | $19,462 | $7,357 | 37.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $11,916 | $5,025 | 42.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 57 | 59 | $7,090 | $4,034 | 56.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 17 | $4,777 | $2,044 | 42.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 62 | 64 | $2,240 | $1,762 | 78.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 31 | $4,464 | $1,310 | 29.3% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 25 | 25 | $2,500 | $918.88 | 36.8% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 21 | 21 | $2,100 | $764.40 | 36.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 22 | 22 | $770.00 | $608.14 | 79.0% |
About Dr. Aaron Tolan, M.D
Dr. Aaron Tolan, M.D is a Internal Medicine healthcare provider based in Clemson, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1881909596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Tolan, M.D has received a total of $5,765 in payments from pharmaceutical and medical device companies, with $1,795 received in 2024. These payments were reported across 368 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($5,765).
As a Medicare-enrolled provider, Tolan has provided services to 2,711 Medicare beneficiaries, totaling 4,172 services with total Medicare billing of $265,782. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics, Pediatrics
- Location Clemson, SC
- Active Since 08/18/2010
- Last Updated 05/11/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1881909596
Products in Payments
- VRAYLAR (Drug) $530.62
- UBRELVY (Drug) $395.28
- QULIPTA (Drug) $292.31
- NURTEC ODT (Drug) $279.15
- Austedo XR (Drug) $252.80
- TRULICITY (Drug) $238.08
- TRELEGY ELLIPTA (Drug) $206.79
- Ozempic (Drug) $195.15
- EMGALITY (Drug) $179.17
- Wegovy (Drug) $173.62
- JARDIANCE (Drug) $173.18
- MOUNJARO (Drug) $163.80
- ELIQUIS (Drug) $158.10
- REXULTI (Drug) $145.21
- GVOKE HYPOPEN (Drug) $137.33
- Leqembi (Drug) $123.80
- AUSTEDO (Drug) $97.15
- Rybelsus (Drug) $82.62
- Dexcom G6 Transmitter (Medical Supply) $77.94
- Cologuard Collection Kit (Device) $71.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clemson
Chad Ward, M.d, M.D
Internal Medicine — Payments: $124,462
Internal Medicine $124,462
William Bedingfield, Md, MD
Internal Medicine — Payments: $7,125
Internal Medicine $7,125
David Liebman, Md, MD
Internal Medicine — Payments: $2,282
Internal Medicine $2,282
Christopher Miles, Md, MD
Internal Medicine — Payments: $2,172
Internal Medicine $2,172
Nardine Smoak, Md, MD
Internal Medicine — Payments: $545.57
Internal Medicine $545.57